Skip to content
DeepViews

NuSkin Enterprises, Inc. (NUS) — Analysis Summary

NuSkin Enterprises, Inc. (NUS) has a market cap of $237.06M with year-over-year revenue growth of -14.3%. Net margin stands at 10.8%. The stock trades at a P/E ratio of -1.1.

Key Takeaways

  • Revenue changed -14.3% year-over-year
  • Net margin of 10.8%
  • P/E ratio of -1.1

Compared to other companies in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector, NUS posted revenue growth of -14.3% and trades at a P/E of -1.1.

[XNYS]

NuSkin Enterprises, Inc. (NUS)

$4.87

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$237.06M
Enterprise Value
$259.33M
P/E Ratio
-1.1
Div Yield
4.93%
EV/EBITDA
6.5
Company Profile
About
About NuSkin Enterprises, Inc.

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

Sector

WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

Employees

8,600

Headquarters

PROVO, UT

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
42
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$542.74M
Total Debt$213.66M
Debt-to-Equity0.39
Cash & Equivalents$189.64M

Cash Flow

Operating Cash Flow$50.81M
Free Cash Flow$10.78M
FCF Margin0.78%
P/FCF Ratio21.99
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$0.24

Dividend Yield

4.93%

Quarterly
Last Ex-Date: 2026-08-28

Dividend History

2026-08-28
CD$0.0600
2026-05-29
CD$0.0600
2026-02-27
CD$0.0600
2025-11-28
CD$0.0600
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.